Skip to main content
PLEASE NOTE: For everyone’s safety, Fasken requires anyone on-site at our Canadian offices to provide proof of full vaccination against COVID-19. This applies to lawyers, staff, clients, service providers and other visitors.
Client Work

Apotex Inc. v. H. Lundbeck A/S

Fasken
Reading Time 1 minute read Subscribe
Client

Lundbeck

Apotex Inc. v. H. Lundbeck A/S
Action instituted by Apotex seeking a declaration of invalidity of Canadian patent no. 1,339,452 covering escitalopram on the grounds of anticipation, obviousness, inutility and insufficient disclosure. During this case : Lundbkeck answered with a counterclaim in infringement of the patent; The action instituted by Apotex was dismissed; The Counterclaim was granted; Apotex was condemned to an accounting of profits; Apotex appeal was discontinued. Lundbeck was advised in these proceedings by a team from Fasken Martineau that included Marie Lafleur, Julie Desrosiers and Christian Leblanc. For more information, see 2013 FC 192.

    Subscribe

    Receive email updates from our team

    Subscribe